Bluebird Bio | 净收入



净收入 更改 日
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Tectonic Therapeutic USD -19.04M 940K 2025-09
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12


Bluebird Bio 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.